Alder Biopharma (ALDR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 23,227 | N/A |
| Receivables | 316 | N/A |
| TOTAL | $25,525 | $N/A |
| Non-Current Assets | ||
| PPE Net | 1,214 | N/A |
| TOTAL | $1,214 | $N/A |
| Total Assets | $26,739 | $N/A |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 2,223 | 0 |
| Accrued Expenses | 2,128 | N/A |
| TOTAL | $23,068 | $N/A |
| Non-Current Liabilities | ||
| Deferred Revenues | 18,717 | N/A |
| TOTAL | $35,659 | $N/A |
| Total Liabilities | $58,727 | $N/A |
| Shareholders' Equity | ||
| Retained earnings | -145,814 | N/A |
| Other shareholders' equity | 111,383 | 0 |
| TOTAL | $-31,988 | $N/A |
| Total Liabilities And Equity | $26,739 | $0 |